Drugs / Prismasate
last change Apr 2024 re-read 3 minutes ago

Prismasate

Developed for
acute kidney injury · metabolic acidosis

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 4 NCT03846258 Comparator May 2019 → Apr 2024 acute kidney injury, metabolic acidosis Mayo Clinic Withdrawn No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Prismasate “Participants randomized to this arm will be started on CRRT using Prismasate as the replacement fluid.” NCT03846258 ↗